Patents by Inventor Grant McClarty

Grant McClarty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EBOLA MONOCLONAL ANTIBODIES
    Publication number: 20170183396
    Abstract: The present disclosure provides antibodies, and antigen-binding fragments thereof that bind to EBOV glycoprotein. The present disclosure further provides hybridoma cell lines and methods for making and using the compositions provided herein.
    Type: Application
    Filed: February 19, 2015
    Publication date: June 29, 2017
    Inventors: Jody BERRY, Grant MCCLARTY, Kelly WARFIELD, Mohammad Javad AMAN
  • Compositions and Methods for Treating Alzheimer's Disease
    Publication number: 20160280742
    Abstract: The present disclosure provides for a hyperimmune preparation comprising human polyclonal antibodies or fragments thereof specific to a cyclic peptide having an amino acid sequence comprising SNK. The cyclic peptide may comprise an amino acid sequence GSNK (SEQ ID NO: 1), SNKG (SEQ ID NO: 2), GSNKG (SEQ ID NO: 3), CSNKG (SEQ ID NO: 4), CGSNKGC (SEQ ID NO: 5), CGSNKGG (SEQ ID NO: 6), or CCGSNKGC (SEQ ID NO: 7). The antibodies in the hyperimmune preparation may have a titer ranging from about 200 to about 400 mean fluorescence intensity (MFI). In one embodiment, greater than about 80% of the antibodies in the hyperimmune preparation are IgG. The fragments of the antibodies are Fab, F(ab?)2, scFv, disulfide linked Fv, or mixtures thereof.
    Type: Application
    Filed: February 29, 2016
    Publication date: September 29, 2016
    Inventors: Neil R. Cashman, Grant McClarty
  • COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20140314773
    Abstract: The present disclosure provides for a hyperimmune preparation comprising human polyclonal antibodies or fragments thereof specific to a cyclic peptide having an amino acid sequence comprising SNK. The cyclic peptide may comprise an amino acid sequence GSNK (SEQ ID NO: 1), SNKG(SEQ ID NO: 2), GSNKG (SEQ ID N0:3), CSNKG (SEQ ID NO: 4), CGSNKGC (SEQ ID NO: 5), CGSNKGG (SEQ ID NO: 6), or CCGSNKGC (SEQ ID NO: 7). The antibodies in the hyperimmune preparation may have a titer ranging from about 200 to about 400 mean fluorescence intensity (MFI). In one embodiment, greater than about 80% of the antibodies in the hyperimmune preparation are IgG. The fragments of the antibodies are Fab, F(ab?)2, scFv, disulfide linked Fv, or mixtures thereof.
    Type: Application
    Filed: November 12, 2012
    Publication date: October 23, 2014
    Inventors: Neil R. Cashman, Grant McClarty